论文部分内容阅读
目的:观察胺碘酮治疗阵发性心房颤动的疗效。方法:60例心房颤动患者随机分为观察组(胺碘酮组)和对照组(普罗帕酮组),每组各30例,胺碘酮组口服胺碘酮0.2/次,3次/d,连服2周;普罗帕酮100 mg/次,3次/d,疗程同胺碘酮组。结果:胺碘酮组总有效率(90.0%)明显优于普罗帕酮组总有效率(56.6%),两组相比有统计学差异(P<0.05)。结论:胺碘酮治疗阵发性心房颤动的有效率较普罗帕酮更有效,安全。
Objective: To observe the efficacy of amiodarone in the treatment of paroxysmal atrial fibrillation. Methods: Sixty patients with atrial fibrillation were randomly divided into observation group (amiodarone group) and control group (propafenone group), 30 cases in each group. The amiodarone group was given amiodarone 0.2 times / , Even for 2 weeks; propafenone 100 mg / time, 3 times / d, treatment with amiodarone group. Results: The total effective rate (90.0%) in amiodarone group was significantly better than that in propafenone group (56.6%). There was significant difference between the two groups (P <0.05). Conclusion: Amiodarone is more effective and safe than propafenone in the treatment of paroxysmal atrial fibrillation.